Creative Planning Bio Xcel Therapeutics, Inc. Transaction History

Creative Planning

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$1.95 - $4.04 $13,650 - $28,280	-7,000 Reduced 34.61%	13,224 $37,000
Q4 2023 Feb 14, 2024	SELL	$2.32 - $5.51 $2,320 - $5,510	-1,000 Reduced 4.71%	20,224 $59,000
Q3 2023 Nov 16, 2023	BUY	$2.49 - $11.85 $52,847 - $251,504	21,224 New	21,224 $53,000
Q4 2020 Jan 29, 2021	SELL	$42.46 - $56.58 $275,862 - $367,600	-6,497 Closed	0 $0
Q3 2020 Nov 05, 2020	BUY	$37.44 - $64.63 $243,247 - $419,901	6,497 New	6,497 $282,000
Q2 2020 Jul 23, 2020	SELL	$17.62 - $58.71 $192,304 - $640,760	-10,914 Closed	0 $0
Q1 2020 May 05, 2020	SELL	$12.26 - $41.14 $48,255 - $161,927	-3,936 Reduced 26.51%	10,914 $244,000
Q4 2019 Jan 30, 2020	BUY	$4.05 - $14.61 $60,142 - $216,958	14,850 New	14,850 $217,000
Q3 2019 Nov 01, 2019	SELL	$7.04 - $11.77 $112,640 - $188,320	-16,000 Closed	0 $0
Q2 2019 Jul 26, 2019	SELL	$8.99 - $11.79 $130,804 - $171,544	-14,550 Reduced 47.63%	16,000 $175,000
Q1 2019 Apr 24, 2019	BUY	$3.49 - $10.47 $106,619 - $319,858	30,550 New	30,550 $302,000
Q4 2018 Feb 01, 2019	SELL	$2.41 - $7.61 $32,173 - $101,593	-13,350 Closed	0 $0
Q3 2018 Oct 25, 2018	BUY	$7.51 - $12.99 $100,258 - $173,416	13,350 New	13,350 $102,000

3.1M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $8.41M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.